Study reveals weight loss injections reduce risk of 42 illnesses but increase chances of 19 others

A new study shows that weight loss injections, like Ozempic and Mounjaro, can lower the risk of 42 illnesses but increase the chances of 19 others. These include arthritis and damage to the gut, pancreas, and kidneys. The risk of pancreatitis, a serious condition, is doubled for users of these injections. The study analyzed medical records of two million Americans from 2017 to 2023. Demand for these injections is rising, with projections of one million users in the UK this year, including many on the NHS. Researchers emphasize the need for monitoring due to the associated risks.